|
Ovid Therapeutics Inc. ithatha indawo engu-#18 kule simo Ukukhula kwenani lentengo yenkampani yenyanga on NGM. Ovid Therapeutics Inc. ithatha indawo engu-#44 kule simo Ukukhula kwentengo yenkampani yeviki on NGM. Ovid Therapeutics Inc. ithatha indawo engu-#50 kule simo Ukwanda kwinani lentengo yenkampani ngaphezu kweminyaka emithathu on NGM. Ovid Therapeutics Inc. ithatha indawo engu-#65 kule simo Ukukhula kwentengo yenkampani yenyanga yezinyanga ezingu-3 on NGM. Ovid Therapeutics Inc. ithatha indawo engu-#72 kule simo I-Capitalization on NGM.
Ovid Therapeutics Inc. ngesilinganiso sesabelo ngasinye ihlanganiswa ngokususelwa emiphumeleni yezitatimende zezezimali ezitholwayo. Umholo ngesabelo ngasinye - isimilo sokushintshaniswa kwesitoko senkampani, esibonisa isabelo senzuzo sincishiselwe ku-1 share. Isilinganiso "seholo ngalinye ngokwesilinganiso" siyakhula kulezo zinkampani lapho, njengomthetho, imali etholwa ngesabelo ngasinye ikhula futhi.
Isilinganiso Ovid Therapeutics Inc. imali engenayo iyonke - uhlu lwezinkampani eziqoqwe ngenani lemali ephelele. Imali engenayo yenkampani noma inzuzo yokulinganisa imali engenayo yeNet ayicabangeli inani eliphelele lamasheya enkampani nokubaluleka kwawo. Uhlu Oluphezulu Lezinkampani Ezihola Inzuzo lunezinkampani ezinkulu kakhulu ezimakethe zamasheya.
|
